Pressure grows to create drugs for 'Superbugs'
Government officials, drug companies and medical experts, faced with outbreaks of antibiotic-resistant "superbugs," are pushing to speed up the approval of new antibiotics, a move that is raising safety concerns among some critics. The need for new antibiotics is so urgent, supporters of an overhaul say, that lengthy studies involving hundreds or thousands of patients should be waived in favor of directly testing such drugs in very sick patients. Influential lawmakers have said they are prepared to support legislation that allows for faster testing.
- MU Compliance Announcement Sparks Concern, Confusion
- Scary Financial Challenges for 2014
- New G-Codes to Pay Doctors for Broad Array of Non-Face-to-Face Care
- Resisting the Healthcare Consolidation Frenzy
- MGMA Urges 'End-to-End' ICD-10 Testing
- 1 in 5 CT Screenings for Lung Cancer Results in Overdiagnosis
- Give Nurses in Wheelchairs a Chance
- HL20: George Halvorson—Expectations for Success
- 3 Better Ways to Market Bariatric Surgery
- LifePoint Bolsters Presence in Michigan's Upper Peninsula